Ajanta Pharma Share Price

2,531.20-13.71 (-0.54%)
Volume: 1,05,355

Closed
Last Updated On: 24 Sep, 2025, 03:58 PM IST

TECHNICALS
COMPARE

2,531.20-13.71 (-0.54%)
Volume: 1,05,355

Stock Recommendations

Potential
Upside
1 Year
Target

BUY

Mean Recos by
12 Analysts

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside

Stock Reports Plus

/10

Stock Score

View Report

Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum

No Rating (NR)

Negative

Neutral

Positive

Unlock Stock Score

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Key Metrics

PE Ratio

(x)

34.00

EPS - TTM

(₹)

74.45

MCap

(₹ Cr.)

31,617.75

Sectoral MCap Rank

PB Ratio

(x)

8.39

Div Yield

(%)

1.11

Face Value

(₹)

2.00

Beta

-0.10

VWAP

(₹)

2,534.37

52W H/L

(₹)

3,428.00 / 2,327.30

Ajanta Pharma share price insights

Intraday fact check
In the last 20 years, only 2.22 % trading sessions saw intraday declines higher than 5 % .
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 23.44% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
Ajanta Pharma Share Price Update
Ajanta Pharma Ltd. share price moved down by -0.54% from its previous close of Rs 2,544.90. Ajanta Pharma Ltd. stock last traded price is 2,531.20
Share Price Value
Today/Current/Last 2,531.202,520.00
Previous Day 2,544.902,542.70

Share Price	Value
Today/Current/Last	2,531.202,520.00
Previous Day	2,544.902,542.70

InsightsAjanta Pharma

Do you find these insights useful?

hate it
meh
love it

Ajanta Pharma Share Price Returns

1 Day	-0.54%
1 Week	-1.16%
1 Month	-4.07%
3 Months	-1.29%
1 Year	-21.47%
3 Years	99.41%
5 Years	142.91%

ET Stock ScreenersTop Score Companies

Check whether Ajanta Pharma belongs to analysts' top-rated companies list?

View Stock Screeners

Ajanta Pharma News & Analysis

View all Ajanta Pharma Share News & Announcements

Ajanta Pharma Share Recommendations

Recent Recos

BUY

Current

Mean Recos by 12 Analysts

Strong
SellSellHoldBuyStrong
Buy

Target₹2030
OrganizationICICI Securities
BUY

Target₹1580
OrganizationICICI Securities
BUY

Analyst Trends

Ratings	Current	1 Week Ago	1 Month Ago	3 Months Ago
Strong Buy	5	4	4	4
Buy	4	4	4	4
Hold	2	2	2	1
Sell	1	1	1	1
Strong Sell	-	-	-	-
# Analysts	12	11	11	10

View all Stock Recommendations

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 23.44% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	1,328.98	1,188.52	1,176.57	1,206.12	1,171.39
Total Income Growth (%)	11.82	1.02	-2.45	2.96	7.51
Total Expenses	992.59	913.04	861.27	909.86	848.54
Total Expenses Growth (%)	8.71	6.01	-5.34	7.23	4.76
EBIT	336.39	275.48	315.30	296.26	322.85
EBIT Growth (%)	22.11	-12.63	6.43	-8.24	15.48
Profit after Tax (PAT)	255.34	225.26	232.88	216.48	245.77
PAT Growth (%)	13.35	-3.27	7.58	-11.92	21.24
EBIT Margin (%)	25.31	23.18	26.80	24.56	27.56
Net Profit Margin (%)	19.21	18.95	19.79	17.95	20.98
Basic EPS (₹)	20.44	18.00	18.60	17.27	19.54

Quarterly \| Annual	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total Income	1,249.19	1,031.87	1,135.15	1,169.25	1,105.64
Total Income Growth (%)	21.06	-9.10	-2.92	5.75	15.20
Total Expenses	919.47	803.05	800.52	859.32	794.36
Total Expenses Growth (%)	14.50	0.32	-6.84	8.18	8.46
EBIT	329.72	228.82	334.63	309.93	311.28
EBIT Growth (%)	44.10	-31.62	7.97	-0.43	36.91
Profit after Tax (PAT)	254.97	193.43	252.45	234.98	236.03
PAT Growth (%)	31.82	-23.38	7.43	-0.44	45.08
EBIT Margin (%)	26.39	22.18	29.48	26.51	28.15
Net Profit Margin (%)	20.41	18.75	22.24	20.10	21.35
Basic EPS (₹)	20.41	15.46	20.16	18.75	18.77

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	4,742.60	4,293.31	3,841.28	3,456.67	2,915.67
Total Revenue Growth (%)	10.46	11.77	11.13	18.55	8.79
Total Expenses	3,553.44	3,179.38	3,096.03	2,547.19	2,015.49
Total Expenses Growth (%)	11.77	2.69	21.55	26.38	0.16
Profit after Tax (PAT)	920.39	816.17	587.98	712.68	653.87
PAT Growth (%)	12.77	38.81	-17.50	8.99	39.81
Operating Profit Margin (%)	26.02	26.63	20.06	27.52	31.43
Net Profit Margin (%)	19.80	19.39	15.71	21.33	22.62
Basic EPS (₹)	73.56	64.82	45.89	82.45	75.09

Quarterly \| Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	4,441.91	4,087.60	3,544.02	3,280.37	2,822.16
Total Revenue Growth (%)	8.67	15.34	8.04	16.24	18.55
Total Expenses	3,261.85	2,990.65	2,844.17	2,379.83	1,920.07
Total Expenses Growth (%)	9.07	5.15	19.51	23.94	8.85
Profit after Tax (PAT)	916.89	807.24	558.72	719.86	675.64
PAT Growth (%)	13.58	44.48	-22.38	6.54	53.16
Operating Profit Margin (%)	27.40	27.79	20.66	28.96	33.43
Net Profit Margin (%)	21.21	20.32	16.37	22.92	24.85
Basic EPS (₹)	73.28	64.11	43.61	83.28	77.59

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	5,014.95	4,638.39	4,679.02	4,055.58	3,778.72
Total Assets Growth (%)	8.12	-0.87	15.37	7.33	13.86
Total Liabilities	1,224.66	1,071.03	1,291.03	791.24	783.09
Total Liabilities Growth (%)	14.34	-17.04	63.17	1.04	8.79
Total Equity	3,790.29	3,567.36	3,387.99	3,264.34	2,995.63
Total Equity Growth (%)	6.25	5.29	3.79	8.97	15.27
Current Ratio (x)	2.85	3.05	2.49	3.50	3.13
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	144.28	161.39	91.52	76.44	168.98

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	4,554.25	4,217.44	4,304.79	3,780.49	3,532.06
Total Assets Growth (%)	7.99	-2.03	13.87	7.03	15.84
Total Liabilities	928.94	803.87	1,058.34	611.31	647.08
Total Liabilities Growth (%)	15.56	-24.04	73.13	-5.53	10.08
Total Equity	3,625.31	3,413.57	3,246.45	3,169.18	2,884.98
Total Equity Growth (%)	6.20	5.15	2.44	9.85	17.21
Current Ratio (x)	3.62	3.88	2.81	4.38	3.56
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	144.28	161.39	91.52	76.44	168.98

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1,157.23	785.07	791.78	562.04	576.31
Net Cash used in Investing Activities	-376.52	65.39	-559.60	-74.10	-282.39
Net Cash flow from Financing Activities	-733.41	-1,051.06	-107.87	-460.04	-318.29
Net Cash Flow	47.30	-200.60	124.31	27.90	-24.37
Closing Cash & Cash Equivalent	176.79	129.23	330.67	205.41	177.99
Closing Cash & Cash Equivalent Growth (%)	36.80	-60.92	60.98	15.41	-10.51
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	1,053.80	735.35	736.29	542.34	466.99
Net Cash used in Investing Activities	-349.60	105.02	-501.31	-66.04	-162.68
Net Cash flow from Financing Activities	-715.71	-1,047.70	-105.12	-457.30	-268.90
Net Cash Flow	-11.51	-207.33	129.86	19.00	35.41
Closing Cash & Cash Equivalent	50.27	61.52	269.69	138.88	120.36
Closing Cash & Cash Equivalent Growth (%)	-18.29	-77.19	94.19	15.39	47.70
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	24.28	22.87	17.35	21.83	21.82
Return on Capital Employed (%)	30.10	29.95	21.21	26.98	29.02
Return on Assets (%)	18.35	17.59	12.56	17.57	17.30
Interest Coverage Ratio (x)	65.32	174.28	151.01	102.45	123.89
Asset Turnover Ratio (x)	0.96	0.90	0.82	0.83	0.79
Price to Earnings (x)	35.71	34.72	26.04	21.83	23.87
Price to Book (x)	8.66	7.93	4.51	4.76	5.21
EV/EBITDA (x)	24.11	22.40	16.95	14.66	15.02
EBITDA Margin (%)	29.13	29.85	23.56	31.27	35.45

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	25.29	23.64	17.21	22.71	23.41
Return on Capital Employed (%)	30.82	30.76	20.75	27.47	30.13
Return on Assets (%)	20.13	19.14	12.97	19.04	19.12
Interest Coverage Ratio (x)	287.95	181.75	159.09	113.01	147.90
Asset Turnover Ratio (x)	0.99	0.93	0.84	0.86	0.83
Price to Earnings (x)	35.84	35.09	27.40	21.60	23.09
Price to Book (x)	9.05	8.28	4.71	4.90	5.40
EV/EBITDA (x)	24.74	22.83	18.03	14.93	15.13
EBITDA Margin (%)	30.64	31.12	24.39	32.81	37.53

Financial InsightsAjanta Pharma

Income (P&L)

- Employee & Interest Expense
  Company has spent less than 1% of its operating revenues towards interest expenses and 23.44% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Ajanta Pharma Share Price Forecast

Price
Revenue
Earnings

Get multiple analysts’ prediction on Ajanta Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Ajanta Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL
Get multiple analysts’ prediction on Ajanta Pharma
High, low, medium predictions for Price
Upcoming predictions for Revenue
Details about company earnings
START FREE TRIAL

Ajanta Pharma Technicals

Buy / Sell Signals
Price Analysis
Pivot Levels & ATR
Chart

Bullish / Bearish signals for Ajanta Pharma basis selected technical indicators and moving average crossovers.
Stochastic Crossover
Bullish signal on weekly chart
Appeared on:

Ajanta Pharma Peer Comparison

Ajanta Pharma Stock Performance
Ratio Performance

CHART
TABLE

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Ajanta Pharma Stock Performance	-0.54	-1.16	-4.07	-1.29	-21.47	99.41	142.91
Suven Pharma Stock Performance	-0.15	-7.07	1.51	-8.86	-24.29	106.78	143.14
Ipca Labs Stock Performance	-3.36	2.84	-4.94	1.05	-8.89	54.29	30.27
Gland Pharma Stock Performance	-1.96	-0.46	1.04	12.06	6.61	-7.73	0.00
J B Chemicals Stock Performance	-1.62	0.15	-2.99	-5.75	-12.79	83.16	268.37
Add More

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Ajanta Pharma	34.00	8.34	24.28	30.10	18.35	11.00	26.02	19.80	73.56	2.85	0.00	0.00
Suven Pharma	134.22	18.67	15.78	13.36	8.83	-3.80	29.74	22.10	10.52	2.43	0.05	0.27
Ipca Labs	43.93	4.08	10.61	15.15	6.27	15.11	15.89	8.80	35.14	2.63	0.19	0.99
Gland Pharma	42.31	3.56	7.63	11.43	6.22	7.94	19.66	12.43	42.40	4.33	0.03	0.29
J B Chemicals	38.62	7.71	19.21	24.69	15.43	16.92	22.94	16.83	42.45	3.04	0.00	0.02
Add More

Annual Ratios (%)

Choose from Peers

Piramal Pharma
Syngene Int.
Emcure Pharmaceuticals Ltd.
Wockhardt
Eris Lifesciences

Choose from Stocks

See All Parameters

Peers InsightsAjanta Pharma

Do you find these insights useful?

hate it
meh
love it

Ajanta Pharma Shareholding Pattern

QOQ Change
Total Shareholdings

Loading...
Showing Ajanta Pharma Shareholding as on Jun 2025
Category Jun 2025 Mar 2025 Dec 2024 Sep 2024
Promoters 66.26 66.26 66.26 66.26
Pledge 14.12 12.61 11.17 11.17
FII 8.86 8.86 9.26 9.11
DII 17.50 17.48 17.02 17.09
Mutual Funds 14.72 15.13 14.89 14.93
Others 7.37 7.39 7.45 7.53

Category	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Promoters	66.26	66.26	66.26	66.26
Pledge	14.12	12.61	11.17	11.17
FII	8.86	8.86	9.26	9.11
DII	17.50	17.48	17.02	17.09
Mutual Funds	14.72	15.13	14.89	14.93
Others	7.37	7.39	7.45	7.53

Showing Shareholding as on Jun 2025

Category	No. of Shares	Percentage	% Change QoQ
Promoters	8,27,63,777	66.26 %	0.00
Pledge	1,16,87,644	14.12 %	1.50
FII	1,10,63,482	8.86 %	0.00
DII	2,18,61,055	17.50 %	0.01
MF	1,83,91,936	14.72 %	-0.41
Others	92,23,785	7.37 %	-0.01

Ajanta Pharma MF Ownership

Nippon India Small Cap Direct-G
Equity: Small Cap
5
- 414.87
  Amount Invested (in Cr.)
- 0.64%
  % of AUM
- 0.00
  % Change (MoM basis)
UTI Flexi Cap Direct-G
Equity: Flexi Cap
1
- 323.48
  Amount Invested (in Cr.)
- 1.26808505%
  % of AUM
- 0.00
  % Change (MoM basis)
Nippon India Pharma Direct-G
Equity: Sectoral-Pharma
3
- 237.68
  Amount Invested (in Cr.)
- 2.84%
  % of AUM
- 0.00
  % Change (MoM basis)

MF Ownership as on 31 August 2025

View all Mutual Fund Schemes

Ajanta Pharma Corporate Actions

Ajanta Pharma Board Meeting/AGM
Ajanta Pharma Dividends
Others

Meeting Date	Announced on	Purpose	Details
Jul 28, 2025	Jul 16, 2025	Board Meeting	Quarterly Results & Others
Jul 17, 2025	Jun 12, 2025	AGM	-
Apr 30, 2025	Apr 22, 2025	Board Meeting	Audited Results & A.G.M.
Jan 30, 2025	Jan 17, 2025	Board Meeting	Quarterly Results
Oct 28, 2024	Oct 17, 2024	Board Meeting	Quarterly Results

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Interim	1400%	28.0	Nov 06, 2024	Oct 25, 2024
Interim	1300%	26.0	Feb 08, 2024	Jan 25, 2024
Interim	500%	10.0	Aug 04, 2023	Jul 25, 2023
Special	750%	15.0	Aug 04, 2023	Jul 24, 2023
Interim	0%	0.0	Aug 04, 2023	Jul 24, 2023

All Types	Ex-Date	Record Date	Announced on	Details
Bonus	Jun 22, 2022	Jun 23, 2022	May 10, 2022	Bonus Ratio: 1 share(s) for every 2 shares held
Splits	Mar 20, 2015	Mar 23, 2015	Jan 28, 2015	Split: Old FV5.0\| New FV:2.0
Bonus	Sep 17, 2013	Sep 18, 2013	Jul 29, 2013	Bonus Ratio: 1 share(s) for every 2 shares held
Splits	Aug 09, 2012	Aug 10, 2012	Apr 26, 2012	Split: Old FV10.0\| New FV:5.0
Bonus	-	-	May 05, 2014	Bonus Ratio: 1 share(s) for every 2 shares held

About Ajanta Pharma

Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 31,617.75 Crore) operating in Pharmaceuticals sector. Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2025. Show More

Executives
Auditors

MB
Mannalal B Agrawal
Chairman
MB
Madhusudan B Agrawal
Vice Chairman
YM
Yogesh M Agrawal
Managing Director
RM
Rajesh M Agrawal
Joint Managing Director
DR
David Rasquinha
Independent Director
MJ
Medha Joshi
Independent Director
RD
Rajesh Dalal
Independent Director
ST
Simi Thapar
Independent Director
AK
Arvind K Agrawal
Chief Financial Officer
GC
Gaurang C Shah
Co. Secretary & Compl. Officer
Show More
B S R & Co. LLP

Industry

Pharma - Indian

Key Indices Listed on

Nifty 500, BSE 500, Nifty Pharma, + 18 more

Address

Ajanta House, Charkop,Kandivli (West),Mumbai, Maharashtra - 400067

Contact

[email protected]

http://www.ajantapharma.com

More Details

FAQs about Ajanta Pharma share

1. What's Ajanta Pharma share price today and what are Ajanta Pharma share returns ?
Ajanta Pharma share price is Rs 2,531.20 as on 24 Sep, 2025, 03:57 PM IST. Ajanta Pharma share price is down by 0.54% based on previous share price of Rs. 2539.2.
2. What is the market cap of Ajanta Pharma?
Ajanta Pharma share has a market capitalization of Rs 31,617.75 Cr. Within Pharmaceuticals sector, it's market cap rank is 19.
3. What is 52 week high/low of Ajanta Pharma share price?
52 Week high of Ajanta Pharma share is Rs 3,428.00 while 52 week low is Rs 2,327.30
4. What are the returns for Ajanta Pharma share?
Return Performance of Ajanta Pharma Shares:
- 1 Week: Ajanta Pharma share price moved down by 1.16%
5. What is the PE & PB ratio of Ajanta Pharma?
The PE ratio of Ajanta Pharma stands at 34.18, while the PB ratio is 8.42.

Trending in Markets

Top Gainers As on 03:59 PM | 24 Sep 2025

Tata Investment8,863.50

725.50 (8.92%)

Minda Corp.579.10

44.61 (8.35%)

Syrma SGS Technology858.40

40.50 (4.96%)

SCI232.48

9.14 (4.10%)

Deepak Fertilisers1,580.30

61.71 (4.07%)

Top Losers As on 03:59 PM | 24 Sep 2025

Adani Power144.50

-17.85 (-11.00%)

Adani Gas667.30

-55.66 (-7.70%)

Balrampur Chini469.70

-26.56 (-5.36%)

Zen Tech1,533.20

-70.30 (-4.39%)

Godrej Properties2,019.10

-84.60 (-4.03%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

BrowseCompanies:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

1 2 3 4 5 6 7 8 9

ETPrime

Ajanta Pharma Share Price

Key Metrics

Ajanta Pharma share price insights

InsightsAjanta Pharma

Key Metrics

Ajanta Pharma Share Price Returns

ET Stock ScreenersTop Score Companies

Ajanta Pharma News & Analysis

Ajanta Pharma Share Recommendations

Recent Recos

Analyst Trends

Ajanta Pharma Financials

Insights

Financial InsightsAjanta Pharma

Ajanta Pharma Share Price Forecast

Get multiple analysts’ prediction on Ajanta Pharma

Get multiple analysts’ prediction on Ajanta Pharma

Get multiple analysts’ prediction on Ajanta Pharma

Ajanta Pharma Technicals

Ajanta Pharma Peer Comparison

Ratio Performance

Peers InsightsAjanta Pharma

Ajanta Pharma Shareholding Pattern

Ajanta Pharma MF Ownership

Nippon India Small Cap Direct-G

UTI Flexi Cap Direct-G

Nippon India Pharma Direct-G

Ajanta Pharma Corporate Actions

About Ajanta Pharma

Executives

Auditors

More Details

FAQs about Ajanta Pharma share

Trending in Markets

Top Gainers As on 03:59 PM | 24 Sep 2025

Top Losers As on 03:59 PM | 24 Sep 2025

Ajanta Pharma Quick Links

Equity Quick Links

More from Markets

1 Day	-0.89%
1 Week	-1.63%
1 Month	-4.48%
3 Months	-1.75%
1 Year	-21.78%
3 Years	98.81%
5 Years	141.94%